MedicationsComments Off on Genentech Announces FDA Approval of Gavreto (pralsetinib) for People With Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancers
Health NewsComments Off on Lung cancer trial of RET inhibitor selpercatinib achieves durable responses in patients with RET gene fusions
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok